CD45-AP specifically associates with CD45, a protein tyrosine phosphatase essential for lymphocyte differentiation and antigen receptor–mediated signal transduction. CD45 is thought to mediate antigen receptor signaling by dephosphorylating regulatory tyrosine residues on Src family protein tyrosine kinases such as Lck. However, the mechanism for regulating CD45 protein tyrosine phosphatase activity remains unclear. CD45-AP–null mice were created to examine the role of CD45-AP in CD45-mediated signal transduction. T and B lymphocytes showed reduced proliferation in response to antigen receptor stimulation. Both mixed leukocyte reaction and cytotoxic T lymphocyte functions of T cells were also markedly decreased in CD45-AP–null mice. Interestingly, the interaction between CD45 and Lck was significantly reduced in CD45-AP–null T cells, indicating that CD45-AP directly or indirectly mediates the interaction of CD45 with Lck. Our data indicate that CD45-AP is required for normal antigen receptor signaling and function in lymphocytes.
Skip Nav Destination
Article navigation
1 June 1998
Article|
June 01 1998
Disruption of Lymphocyte Function and Signaling in CD45–associated Protein–null Mice
Akio Matsuda,
Akio Matsuda
From the *Department of Pathology, Roger Williams Hospital-Brown University, Providence, Rhode Island 02908; and the ‡Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892
Search for other works by this author on:
Satoshi Motoya,
Satoshi Motoya
From the *Department of Pathology, Roger Williams Hospital-Brown University, Providence, Rhode Island 02908; and the ‡Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892
Search for other works by this author on:
Shioko Kimura,
Shioko Kimura
From the *Department of Pathology, Roger Williams Hospital-Brown University, Providence, Rhode Island 02908; and the ‡Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892
Search for other works by this author on:
Renee McInnis,
Renee McInnis
From the *Department of Pathology, Roger Williams Hospital-Brown University, Providence, Rhode Island 02908; and the ‡Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892
Search for other works by this author on:
Abby L. Maizel,
Abby L. Maizel
From the *Department of Pathology, Roger Williams Hospital-Brown University, Providence, Rhode Island 02908; and the ‡Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892
Search for other works by this author on:
Akiko Takeda
Akiko Takeda
From the *Department of Pathology, Roger Williams Hospital-Brown University, Providence, Rhode Island 02908; and the ‡Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892
Search for other works by this author on:
Akio Matsuda
From the *Department of Pathology, Roger Williams Hospital-Brown University, Providence, Rhode Island 02908; and the ‡Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892
Satoshi Motoya
From the *Department of Pathology, Roger Williams Hospital-Brown University, Providence, Rhode Island 02908; and the ‡Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892
Shioko Kimura
From the *Department of Pathology, Roger Williams Hospital-Brown University, Providence, Rhode Island 02908; and the ‡Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892
Renee McInnis
From the *Department of Pathology, Roger Williams Hospital-Brown University, Providence, Rhode Island 02908; and the ‡Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892
Abby L. Maizel
From the *Department of Pathology, Roger Williams Hospital-Brown University, Providence, Rhode Island 02908; and the ‡Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892
Akiko Takeda
From the *Department of Pathology, Roger Williams Hospital-Brown University, Providence, Rhode Island 02908; and the ‡Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892
Address correspondence to Akiko Takeda, Department of Pathology, Roger Williams Hospital-Brown University, 825 Chalkstone Ave., Providence, RI 02908. Phone: 401-456-6557; Fax: 401-456-6569; E-mail: [email protected]
Satoshi Motoya's present address is First Department of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan 060
Received:
December 30 1997
Revision Received:
March 04 1998
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1998
J Exp Med (1998) 187 (11): 1863–1870.
Article history
Received:
December 30 1997
Revision Received:
March 04 1998
Citation
Akio Matsuda, Satoshi Motoya, Shioko Kimura, Renee McInnis, Abby L. Maizel, Akiko Takeda; Disruption of Lymphocyte Function and Signaling in CD45–associated Protein–null Mice . J Exp Med 1 June 1998; 187 (11): 1863–1870. doi: https://doi.org/10.1084/jem.187.11.1863
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement